The first article was about a cancer drug, bortezomib, that was used in an animal study to treat inflammatory disease. The cancer drug induced cell death in only the harmful (active and proliferating) T-cells.
The second article was about a new protein from Compugen called CGEN-15001 that was found to abolish recurring relapses of multiple sclerosis in an animal study. The protein also delayed the onset of the disease. The protein apparently has some effect on the regulatory pathways in the immune system.
Both seem pretty interesting.